Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8002 USD | +0.15% | +0.74% | +8.87% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.87% | 21.58M | |
+14.39% | 110B | |
+1.61% | 30.2B | |
+12.31% | 22.22B | |
-12.17% | 18.53B | |
-9.04% | 16.84B | |
+16.96% | 16.25B | |
-5.37% | 12.03B | |
+2.10% | 10.93B | |
-17.13% | 8.36B |
- Stock Market
- Equities
- ALPP Stock
- News Alpine 4 Holdings, Inc.
- Alpine 4 Holdings Prices $24 Million Registered Direct Offering; Shares Fall